Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 223

Similar articles for PubMed (Select 15888515)

1.

Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential.

Ashton CH, Moore PB, Gallagher P, Young AH.

J Psychopharmacol. 2005 May;19(3):293-300. Review.

PMID:
15888515
2.

Potential antipsychotic properties of central cannabinoid (CB1) receptor antagonists.

Roser P, Vollenweider FX, Kawohl W.

World J Biol Psychiatry. 2010 Mar;11(2 Pt 2):208-19. doi: 10.3109/15622970801908047. Review.

PMID:
20218784
3.

Cannabinoids in clinical practice.

Williamson EM, Evans FJ.

Drugs. 2000 Dec;60(6):1303-14. Review.

PMID:
11152013
4.

Therapeutic potential of cannabinoids in CNS disease.

Croxford JL.

CNS Drugs. 2003;17(3):179-202. Review.

PMID:
12617697
5.

Endocannabinoid system dysfunction in mood and related disorders.

Ashton CH, Moore PB.

Acta Psychiatr Scand. 2011 Oct;124(4):250-61. doi: 10.1111/j.1600-0447.2011.01687.x. Epub 2011 Mar 9. Review.

PMID:
21916860
6.

[Cannabis and cannabinoids as drugs].

Khiabani HZ, Mørland J.

Tidsskr Nor Laegeforen. 2007 Mar 1;127(5):579-82. Review. Norwegian.

7.

Examining the roles of cannabinoids in pain and other therapeutic indications: a review.

Turcotte D, Le Dorze JA, Esfahani F, Frost E, Gomori A, Namaka M.

Expert Opin Pharmacother. 2010 Jan;11(1):17-31. doi: 10.1517/14656560903413534. Review.

PMID:
20001426
8.

Psychomotor performance in relation to acute oral administration of Delta9-tetrahydrocannabinol and standardized cannabis extract in healthy human subjects.

Roser P, Gallinat J, Weinberg G, Juckel G, Gorynia I, Stadelmann AM.

Eur Arch Psychiatry Clin Neurosci. 2009 Aug;259(5):284-92. doi: 10.1007/s00406-009-0868-5. Epub 2009 Feb 17.

PMID:
19224107
9.

Cannabis and psychiatric disorders: it is not only addiction.

Leweke FM, Koethe D.

Addict Biol. 2008 Jun;13(2):264-75. doi: 10.1111/j.1369-1600.2008.00106.x. Review.

PMID:
18482435
10.

Differential effects of cannabis extracts and pure plant cannabinoids on hippocampal neurones and glia.

Ryan D, Drysdale AJ, Pertwee RG, Platt B.

Neurosci Lett. 2006 Nov 20;408(3):236-41. Epub 2006 Sep 25.

PMID:
16997463
11.

Cannabinoids in the treatment of pain and spasticity in multiple sclerosis.

Smith PF.

Curr Opin Investig Drugs. 2002 Jun;3(6):859-64. Review.

PMID:
12137404
12.

[Cannabinoids in the control of pain].

Shaladi AM, Crestani F, Tartari S, Piva B.

Recenti Prog Med. 2008 Dec;99(12):616-24. Review. Italian.

PMID:
19388223
13.

Cancer cachexia and cannabinoids.

Gorter RW.

Forsch Komplementarmed. 1999 Oct;6 Suppl 3:21-2. Review.

PMID:
10575285
14.
15.

Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug.

Zuardi AW, Crippa JA, Hallak JE, Moreira FA, Guimarães FS.

Braz J Med Biol Res. 2006 Apr;39(4):421-9. Epub 2006 Apr 3. Review.

16.

Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects.

Zuardi AW, Shirakawa I, Finkelfarb E, Karniol IG.

Psychopharmacology (Berl). 1982;76(3):245-50.

PMID:
6285406
17.

Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain.

Iskedjian M, Bereza B, Gordon A, Piwko C, Einarson TR.

Curr Med Res Opin. 2007 Jan;23(1):17-24.

PMID:
17257464
18.

Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.

Devinsky O, Cilio MR, Cross H, Fernandez-Ruiz J, French J, Hill C, Katz R, Di Marzo V, Jutras-Aswad D, Notcutt WG, Martinez-Orgado J, Robson PJ, Rohrback BG, Thiele E, Whalley B, Friedman D.

Epilepsia. 2014 Jun;55(6):791-802. doi: 10.1111/epi.12631. Epub 2014 May 22. Review.

PMID:
24854329
19.

Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma.

Ligresti A, Moriello AS, Starowicz K, Matias I, Pisanti S, De Petrocellis L, Laezza C, Portella G, Bifulco M, Di Marzo V.

J Pharmacol Exp Ther. 2006 Sep;318(3):1375-87. Epub 2006 May 25.

20.

Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders.

Campos AC, Moreira FA, Gomes FV, Del Bel EA, Guimarães FS.

Philos Trans R Soc Lond B Biol Sci. 2012 Dec 5;367(1607):3364-78. doi: 10.1098/rstb.2011.0389. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk